Findings

What do systematic reviews say?

3 questions · 3 findings · 3 reviews

No studies found 1 · 33.3%GRADE not reported 1 · 33.3%Very low 0 · 0%Low 0 · 0%Moderate 1 · 33.3%High 0 · 0%

Adverse events · people with multifocal motor neuropathy

The review found no eligible studies for this question.

1 finding from 1 review

Immunoglobulin for multifocal motor neuropathy 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adverse events · people with postpolio syndrome

1 finding from 1 review

Treatment for postpolio syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 212 participants
GRADE not reported

Number of patients with adverse events attributed to treatment · patients with Guillain‐Barré syndrome

IVIg showed no clear difference in number of participants with adverse events attributed to treatment compared with PE (moderate certainty).

1 finding from 1 review

Intravenous immunoglobulin for Guillain‐Barré syndrome 2014 · Cochrane Headline outcomes only
RR 0.84 [0.54, 1.3]
4 studies · 388 participants
Moderate